Skip to main content

Advertisement

SpringerLink
Log in

Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation

  • Alimmentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Barrett’s esophagus is a well-known acquired condition resulting from gastroesophageal reflux disease (GERD). However, it is still unknown whether Barrett’s esophagus develops gradually over time in patients with GERD. To address this issue, we investigated the change in the prevalence and length of short-segment Barrett’s esophagus (SSBE) over time.

Methods

From January 2005 to March 2007, we enrolled 5338 patients who received upper gastrointestinal endoscopy. Prevalence and length of endoscopically identified SSBE were evaluated within groups divided on the basis of 10-year age intervals. The factors possibly influencing SSBE length such as symptoms, antacid use, and endoscopic findings were also evaluated. Additionally, the length change in 236 patients with histologically confirmed Barrett’s esophagus was evaluated over a 2-year follow-up.

Results

Of the 5338 enrolled patients, 1997 had SSBE. The prevalence of endoscopically identified SSBE was significantly higher and its length was significantly longer in elderly patients. Multiple regression analysis showed that age, presence of reflux esophagitis, reflux symptoms, and hiatal hernia were positively correlated with SSBE length. Analysis of the 2-year follow-up study of histologically confirmed SSBE revealed significant extension of Barrett’s length in 28.0% of 236 patients. Presence of reflux symptoms and hiatal hernia were identified as positive predictors and proton pump inhibitor administration as a negative predictor of SSBE elongation.

Conclusions

Positive predictors for the extension of SSBE were presence of hiatal hernia and reflux symptoms, but not age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett’s) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918–922.

    PubMed  CAS  Google Scholar 

  2. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510–513.

    PubMed  CAS  Google Scholar 

  3. Fass R, Ofman JJ. Gastroesophageal reflux disease-should we adopt a new conceptual framework? Am J Gastroenterol 2002;97:1901–1909.

    PubMed  Google Scholar 

  4. Cameron AJ, Lomboy CT. Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241–1245.

    PubMed  CAS  Google Scholar 

  5. Fass R, Hell RW, Garewal HS, Martinez P, Pulliam G, Wendel C, et al. Correlation of oesophageal acid exposure with Barrett’s oesophagus length. Gut 2001;48:310–313.

    Article  PubMed  CAS  Google Scholar 

  6. Tharalson EF, Martinez SD, Garewal HS, Sampliner RE, Cui H, Pulliam G, et al. Relationship between rate of change in acid exposure along the esophagus and length of Barrett’s epithelium. Am J Gastroenterol 2002;97:851–856.

    Article  PubMed  Google Scholar 

  7. Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, et al. Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study. Gut 1999;45:489–494.

    PubMed  CAS  Google Scholar 

  8. Malesci A, Savarino V, Zentilin P, Belicchi M, Mela GS, Lapertosa G, et al. Partial regression of Barrett’s esophagus by longterm therapy with high-dose omeprazole. Gastrointest Endosc 1996;44:700–705.

    Article  PubMed  CAS  Google Scholar 

  9. Schell TG. Acid suppression and adenocarcinoma of the esophagus: cause or cure? Am J Gastroenterol 2004;99:1884–1886.

    Article  PubMed  Google Scholar 

  10. El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett’s esophagus. Am J Gastroenterol 2004;99:1877–1883.

    Article  PubMed  CAS  Google Scholar 

  11. Hillman LC, Chiragakis L, Shadbolt B, Kaye GL, Clarke AC. Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagus. Med J Aust 2004;180:387–391.

    PubMed  Google Scholar 

  12. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett’s esophagus. Am J Gastroenterol 1997;92:582–585.

    PubMed  CAS  Google Scholar 

  13. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of factors predictive of complete regression of Barrett’s esophagus. Am J Gastroenterol 1999;94:3420–3426.

    Article  PubMed  CAS  Google Scholar 

  14. Sharma P. Barrett esophagus: will effective treatment prevent the risk of progression to esophageal adenocarcinoma? Am J Med 2004;117Suppl 5A:79S–85S.

    PubMed  Google Scholar 

  15. Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023–1029.

    Article  PubMed  CAS  Google Scholar 

  16. Armstrong D. Review article: towards consistency in the endoscopic diagnosis of Barrett’s oesophagus and columnar metaplasia. Aliment Pharmacol Ther 2004;20Suppl 5:40–47.

    Article  PubMed  Google Scholar 

  17. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392–1399.

    Article  PubMed  Google Scholar 

  18. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172–180.

    PubMed  CAS  Google Scholar 

  19. Amano K, Adachi K, Katsube T, Watanabe M, Kinoshita Y. Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly. J Gastroenterol Hepatol 2001;16:132–136.

    Article  PubMed  CAS  Google Scholar 

  20. Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy 1969;3:87–97.

    Article  Google Scholar 

  21. Asayama M, Shibata M, Kondo Y, Tauchi M, Yanagawa T, Sato S, et al. Retrospective cohort study of chronological change of short-segment Barrett’s esophagus. Dig Endosc 2005;17:28–31.

    Article  Google Scholar 

  22. Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, et al. Risk factors for dysplasia in patients with Barrett’s esophagus: results from a multicenter consortium. Dig Dis Sci 2003;48:1537–1541.

    Article  PubMed  Google Scholar 

  23. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett’s esophagus. Dig Dis Sci 1992;37:137–143.

    Article  PubMed  CAS  Google Scholar 

  24. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212–215.

    PubMed  CAS  Google Scholar 

  25. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett’s esophagus: a prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012–2016.

    PubMed  CAS  Google Scholar 

  26. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277–285.

    Article  PubMed  CAS  Google Scholar 

  27. Amano Y, Kushiyama Y, Ishihara S, et al. Barrett’s esophagus with predominant intestinal metaplasia correlates with superficial COX-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by NSAIDs usage. Aliment Pharmacol Ther 2004;20:793–802.

    Article  PubMed  CAS  Google Scholar 

  28. Amano Y, Kushiyama Y, Yuki T, Yuki T, Takahashi Y, Chinuki D, et al. Prevalence of and risk factors for Barrett’s esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol 2006;41:873–879.

    Article  PubMed  Google Scholar 

  29. Dickman R, Green C, Chey WD, Jones MP, Eisen GM, Ramirez F, et al. Clinical predictors of Barrett’s esophagus length. Gastrointest Endosc 2005;62:675–681.

    Article  PubMed  Google Scholar 

  30. Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. Hiatal hernia and acid reflux frequency predict presence and length of Barrett’s esophagus. Dig Dis Sci 2002;47:256–264.

    Article  PubMed  Google Scholar 

  31. Wakelin DE, Al-Mutawa T, Wendel C, Green C, Garewal HS, Fass R. A predictive model for length of Barrett’s esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc 2003;58:350–355.

    Article  PubMed  Google Scholar 

  32. Conio M, Filiberti R, Blanchi S, Ferraris R, Marchi S, Ravelli P, et al. Risk factors for Barrett’s esophagus: a case control study. Int J Cancer 2002;97:225–229.

    Article  PubMed  CAS  Google Scholar 

  33. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 2002;123:461–467.

    Article  PubMed  Google Scholar 

  34. Voutilainen M, Färkkilä M, Juhola M, Nuorva K, Mauranen K, Mäntynen T, et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol 1999;94:913–918.

    Article  PubMed  CAS  Google Scholar 

  35. Wilkinson SP, Biddlestone L, Gore S, Shepherd NA. Regression of columnar-lined (Barrett’s) oesophagus with omeprazole 40 mg daily: results of 5 years of continuous therapy. Aliment Pharmacol Ther 1999;13:1205–1209.

    Article  PubMed  CAS  Google Scholar 

  36. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett’s esophagus and the effects of acid suppression. Gastroenterology 1999;117:327–335.

    Article  PubMed  CAS  Google Scholar 

  37. Amano Y, Chinuki D, Yuki T, Takahashi Y, Ishimura N, Kazumori H, et al. Efficacy of proton pump inhibitors for cellular proliferation and apoptosis in Barrett’s oesophagus with different mucin phenotypes. Aliment Pharmacol Ther 2006;24Suppl 4:41–48.

    Google Scholar 

  38. Horwhat JD, Baroni D, Maydonovitch C, Osgard E, Ormseth E, Rueda-Pedraza E, et al. Normalization of intestinal metaplasia in the esophagus and esophagogastric junction: incidence and clinical data. Am J Gastroenterol 2007;102:497–506.

    Article  PubMed  Google Scholar 

  39. Overholt BF. Acid suppression and reepithelialization after ablation of Barrett’s esophagus. Dig Dis 2000–2001;18:232–239.

    Article  PubMed  Google Scholar 

  40. Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett’s esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy. Am J Surg Pathol 1998;22:239–245.

    Article  PubMed  CAS  Google Scholar 

  41. Amano Y, Kushiyama Y, Yuki T, Takahashi Y, Chinuki D, Ishimura N, et al. Predictors for squamous re-epithelialization of Barrett’s esophagus after endoscopic biopsy. J Gastroenterol Hepatol 2007:22;901–907.

    Article  PubMed  Google Scholar 

  42. Neumann CS, Iqbal TH, Cooper BT. Long term continuous omeprazole treatment of patients with Barrett’s oesophagus. Aliment Pharmacol Ther 1995;9:451–454.

    Article  PubMed  CAS  Google Scholar 

  43. Katsube T, Adachi K, Furuta K, Miki M, Fujisawa T, Azumi T, et al. Difference in localization of esophageal mucosal breaks among grades of esophagitis. J Gastroenterol Hepatol 2006;21:1656–1659.

    Article  PubMed  Google Scholar 

  44. Edebo A, Vieth M, Tam W, Bruno M, van Berkel AM, Stolte M, et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007;20:232–238.

    Article  PubMed  CAS  Google Scholar 

  45. Moriyama N, Amano Y, Okita K, Mishima Y, Ishihara S, Kinoshita Y. Localization of early stage dysplastic Barrett’s lesion in patients with short segment Barrett’s esophagus. Am J Gastroenterol 2006;101:2666–2667.

    PubMed  Google Scholar 

  46. Dekel R, Wakelin DE, Wendel C, Green C, Sampliner RE, Garewal HS, et al. Progression or regression of Barrett’s esophagus—is it all in the eye of the beholder? Am J Gastroenterol 2003;98:2612–2615.

    PubMed  Google Scholar 

  47. Egger K, Meining A, Werner M, Höfler H, Classen M, Rösch T. Endoscopic measurement of Barrett’s esophagus length is unreliable—a prospective comparative biopsy study. Z Gastroenterol 2004;42:499–504.

    Article  PubMed  CAS  Google Scholar 

  48. Guda NM, Partington S, Vakil N. Inter- and intra-observer variability in the measurement of length at endoscopy: implications for the measurement of Barrett’s esophagus. Gastrointest Endosc 2004;59:655–658.

    Article  PubMed  Google Scholar 

  49. El-Serag HB, Garewel H, Kuebeler M, Sampliner RE. Is the length of newly diagnosed Barrett’s esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol 2004;2:296–300.

    Article  PubMed  Google Scholar 

  50. Amano Y, Kinoshita Y. Barrett’s esophagus: perspectives on its diagnosis and management in Asian populations. Gastroenterol Hepatol 2008;4:45–53.

    Google Scholar 

  51. Amano Y, Ishimura N, Furuta K, Takahashi Y, Chinuki D, Mishima Y, et al. Which landmark results in a more consistent diagnosis of Barrett’s esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc 2006;64:206–211.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Shimane University, School of Medicine, Izumo, Japan

    Koichi Okita, Yoshiko Takahashi, Yuko Mishima, Nobuyuki Moriyama, Norihisa Ishimura, Shunji Ishihara & Yoshikazu Kinoshita

  2. Division of Gastrointestinal Endoscopy, Shimane University Hospital, 89-1 Enya, Izumo, Shimane, 693-8501, Japan

    Yuji Amano

Authors
  1. Koichi Okita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuji Amano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshiko Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuko Mishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobuyuki Moriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norihisa Ishimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shunji Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshikazu Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okita, K., Amano, Y., Takahashi, Y. et al. Barrett’s esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol 43, 928–934 (2008). https://doi.org/10.1007/s00535-008-2261-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-008-2261-y

Key words

Search

Navigation